{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:47:50Z","timestamp":1771552070082,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["H0517\/81560132"],"award-info":[{"award-number":["H0517\/81560132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970583"],"award-info":[{"award-number":["81970583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Supporting Project for the Foregoers of Main Disciplines of Jiangxi Province","award":["20162BCB22023"],"award-info":[{"award-number":["20162BCB22023"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Observational studies suggest that hepatorenal syndrome (HRS) patients who receive pharmacological therapy before orthotopic liver transplantation display a post-transplant outcome similar to those without HRS. The aim of this study was to comprehensively compare and rank the pharmacological therapies for HRS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We reviewed PubMed, Elsevier, Medline, and the Cochrane Central Register of Controlled Trials (CENTRAL) for studies that were published between 1 January 1999 and 24 February 2018. The primary endpoint was reversal of HRS. The secondary endpoints were the changes in serum creatinine (Scr) and serum sodium. We evaluated the different therapeutic strategies using network meta-analysis on the basis of Bayesian methodology.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The study included 24 articles with 1,419 participants evaluating seven different therapeutic strategies for HRS. The most effective treatments to induce reversal of HRS were terlipressin plus albumin, noradrenaline plus albumin, and terlipressin, which had a surface under the cumulative ranking curve (SUCRA) of 0.086, 0.151, and 0.451, respectively. The top two treatments for decreasing Scr were dopamine plus furosemide plus albumin (rank probability: 0.620) and terlipressin plus albumin (rank probability: 0.570). For increasing serum sodium, the optimal treatment was octreotide plus midodrine plus albumin (rank probability: 0.800), followed by terlipressin plus albumin (rank probability: 0.544).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Terlipressin plus albumin and dopamine plus furosemide plus albumin should be prioritized for decreasing Scr in HRS, and octreotide plus midodrine plus albumin was the most effective at increasing serum sodium. Terlipressin plus albumin showed a comprehensive effect in both decreasing Scr and increasing serum sodium.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/gastro\/goz043","type":"journal-article","created":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T11:18:48Z","timestamp":1565522328000},"page":"111-118","source":"Crossref","is-referenced-by-count":14,"title":["Pharmacological treatment of hepatorenal syndrome: a network meta-analysis"],"prefix":"10.1093","volume":"8","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Long","sequence":"first","affiliation":[{"name":"Grade 2013, the Second Clinical Medical College of Nanchang University, Nanchang, Jiangxi, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Xin","family":"Li","sequence":"first","affiliation":[{"name":"Grade 2015, the Queen Mary College of Nanchang University, Nanchang, Jiangxi, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gao-Si","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,9,13]]},"reference":[{"key":"2020050406474930500_goz043-B1","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gines","year":"2003","journal-title":"Lancet"},{"key":"2020050406474930500_goz043-B2","first-page":"1310","article-title":"Diagnosis, prevention, and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"2020050406474930500_goz043-B3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/gut.2006.107789","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"84","author":"Salerno","year":"2008","journal-title":"Postgrad Med J"},{"key":"2020050406474930500_goz043-B4","first-page":"36","volume-title":"Clinical Disorders of Renal Function in Cirrhosis with Ascites. Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment","author":"Gin\u00e8s","year":"1999"},{"key":"2020050406474930500_goz043-B5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"2020050406474930500_goz043-B6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of hepatorenal syndrome in cirrhosis","volume":"105","author":"Gin\u00e8s","year":"1993","journal-title":"Gastroenterology"},{"key":"2020050406474930500_goz043-B7","doi-asserted-by":"crossref","first-page":"e107466.","DOI":"10.1371\/journal.pone.0107466","article-title":"Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis","volume":"9","author":"Nassar Junior","year":"2014","journal-title":"PLoS One"},{"key":"2020050406474930500_goz043-B8","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.cld.2014.07.006","article-title":"Transjugular intrahepatic portosystemic shunt","volume":"18","author":"Patidar","year":"2014","journal-title":"Clin Liver Dis"},{"key":"2020050406474930500_goz043-B9","first-page":"CD005162","article-title":"Terlipressin for hepatorenal syndrome","volume":"18","author":"Lise","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050406474930500_goz043-B10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"key":"2020050406474930500_goz043-B11","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"2020050406474930500_goz043-B12","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.jhep.2008.01.010","article-title":"Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis","volume":"48","author":"Angeli","year":"2008","journal-title":"J Hepatol"},{"key":"2020050406474930500_goz043-B13","doi-asserted-by":"crossref","first-page":"880.","DOI":"10.1001\/jama.2016.20899","article-title":"Transjugular intrahepatic portosystemic shunts","volume":"317","author":"Sankar","year":"2017","journal-title":"JAMA"},{"key":"2020050406474930500_goz043-B14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MEG.0000000000000537","article-title":"Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation","volume":"28","author":"Mattos","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2020050406474930500_goz043-B15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11255-010-9725-8","article-title":"Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis","volume":"43","author":"Dobre","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"2020050406474930500_goz043-B16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/0253-7613.106436","article-title":"Survival benefits of terlipressin and non-responder state in hepatorenal syndrome: a meta-analysis","volume":"45","author":"Hiremath","year":"2013","journal-title":"Indian J Pharmacol"},{"key":"2020050406474930500_goz043-B17","first-page":"CD003044","article-title":"Non-absorbable disaccharides versus placebo\/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis","volume":"6","author":"Gluud","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050406474930500_goz043-B18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"2020050406474930500_goz043-B19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1214\/ss\/1177011136","article-title":"Inference from iterative simulation using multiple sequences","volume":"7","author":"Gelman","year":"1992","journal-title":"Stat Sci"},{"key":"2020050406474930500_goz043-B20","doi-asserted-by":"crossref","first-page":"e76654.","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"2020050406474930500_goz043-B21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jrsm.1054","article-title":"Automating network meta-analysis","volume":"3","author":"Van","year":"2012","journal-title":"Res Synth Methods"},{"key":"2020050406474930500_goz043-B22","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1002\/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0","article-title":"Borrowing strength from external trials in a meta-analysis","volume":"15","author":"Higgins","year":"1996","journal-title":"Stat Med"},{"key":"2020050406474930500_goz043-B23","first-page":"323","article-title":"Bias in meta-analysis and funnel plot asymmetry","volume":"68","author":"Biljana","year":"1999","journal-title":"Stud Health Technol Inform"},{"key":"2020050406474930500_goz043-B24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/039139880903200303","article-title":"Terlipressin for hepatorenal syndrome: a meta-analysis of randomized trials","volume":"32","author":"Fabrizio","year":"2009","journal-title":"Int J Artif Organs"},{"key":"2020050406474930500_goz043-B25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on post-transplantation outcome","volume":"40","author":"Restuccia","year":"2004","journal-title":"J Hepatol"},{"key":"2020050406474930500_goz043-B26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00003246-199905000-00023","article-title":"Prognostic usefulness of sco ring systems in critically ill patients with severe acute pancreatitis","volume":"27","author":"Williams","year":"1999","journal-title":"J Crit Care Med"},{"key":"2020050406474930500_goz043-B27","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","article-title":"Hyponatremia in cirrhosis: results of a patient population survey","volume":"44","author":"Angeli","year":"2006","journal-title":"Hepatology"},{"key":"2020050406474930500_goz043-B28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00007890-199102000-00030","article-title":"Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients","volume":"51","author":"Gonwa","year":"1991","journal-title":"Transplantation"},{"key":"2020050406474930500_goz043-B29","first-page":"148","article-title":"Impact of pretransplant renal function on survival after liver transplantation","volume":"93","author":"Gonwa","year":"1995","journal-title":"Transplantation"},{"key":"2020050406474930500_goz043-B30","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/jhep.2002.33160","article-title":"Pretransplant renal function predicts survival in patients undergoing orthotopic liver tran-splantation","volume":"35","author":"Nair","year":"2002","journal-title":"Hepatology"},{"key":"2020050406474930500_goz043-B31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/MEG.0b013e3283407158","article-title":"Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score","volume":"23","author":"Cho","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2020050406474930500_goz043-B32","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"2020050406474930500_goz043-B33","first-page":"134","article-title":"Octreotide blunts postprandial splanchnic hyperemia in cirrhotic patients: a double-blind randomized echo-Doppler study","volume":"21","author":"Buonamico","year":"1995","journal-title":"Hepatology"},{"key":"2020050406474930500_goz043-B34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0676.1996.tb00733.x","article-title":"Short and long-term haemodynamic response to octreotide in portal hypertensive patients: a double-blind, controlled study","volume":"16","author":"Zironi","year":"2008","journal-title":"Liver"},{"key":"2020050406474930500_goz043-B35","first-page":"761","article-title":"Somatostatine, octreotide et hypertension portale","volume":"18","author":"Silvain","year":"1994","journal-title":"Gastroenterol Clin Biol"},{"key":"2020050406474930500_goz043-B36","first-page":"CD011532","article-title":"Terlipressin versus other vasoactive drugs for hepatorenal syndrome","volume":"9","author":"Israelsen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050406474930500_goz043-B37","doi-asserted-by":"crossref","first-page":"e6235.","DOI":"10.5867\/medwave.2015.6235","article-title":"Noradrenaline or terlipressin for hepatorenal syndrome?","volume":"15(Suppl 2)","author":"Celis","year":"2015","journal-title":"Medwave"}],"container-title":["Gastroenterology Report"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/gastro\/article-pdf\/8\/2\/111\/33160426\/goz043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/gastro\/article-pdf\/8\/2\/111\/33160426\/goz043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T11:12:05Z","timestamp":1588590725000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/gastro\/article\/8\/2\/111\/5569488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,9,13]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/gastro\/goz043","relation":{},"ISSN":["2052-0034"],"issn-type":[{"value":"2052-0034","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2019,9,13]]}}}